Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer

<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Jeyachandran Dhanapriya (Údar), Sankarakumar GaneshAravind (Údar), Thanigachalam Dineshkumar (Údar), Ramanathan Sakthirajan (Údar), Balasubramaniyan T (Údar), Natarajan Gopalakrishnan (Údar)
Formáid: LEABHAR
Foilsithe / Cruthaithe: Archives of Clinical Nephrology - Peertechz Publications, 2017-03-27.
Ábhair:
Rochtain ar líne:Connect to this object online.
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

Connect to this object online.

3rd Floor Main Library

Sonraí sealbhúcháin ó 3rd Floor Main Library
Gairmuimhir: A1234.567
Cóip 1 Ar fáil